Table 4.
Quality of life (QOL) comparison between baseline and 3 month follow-up of trial for patients using pancreatic enzymes open label after trial completion
| Baseline | 3 month follow-up after trial conclusion | ||||
|---|---|---|---|---|---|
| QOL parameter | Mean | N | Mean | t | p Value |
| Dysphoria | 50.60±26.81 | 31 | 89.42±10.35 | −9.00 | 0.000 |
| Interference w/activity | 44.95±21.96 | 29 | 82.27±15.67 | −9.32 | 0.000 |
| Body image | 66.59±26.37 | 29 | 90.73±10.51 | −5.64 | 0.000 |
| Health worry | 64.44±19.57 | 30 | 87.50±12.52 | −5.99 | 0.000 |
| Food avoidance | 23.61±21.56 | 30 | 72.78±21.43 | −9.91 | 0.000 |
| Social reaction | 58.27±21.85 | 31 | 85.89±11.96 | −7.98 | 0.000 |
| Sexual | 73.28±32.86 | 29 | 93.53±10.89 | −3.76 | 0.000 |
| Relationships | 62.93±26.97 | 29 | 92.24±11.77 | −7.21 | 0.000 |
| Overall score | 52.65±18.87 | 25 | 86.35±9.38 | −9.63 | 0.000 |